Clinical Trial: MRI-Guided Radiation Therapy for Unresectable Cancer of the Pancreas 

Summary

ViewRay, Inc. has launched a multi-center, prospective, single-arm clinical trial for inoperable, locally advanced or borderline resectable pancreatic cancer using the MRIdian system. The researchers and doctors participating in this study are members of the Clinical Cooperative Think Tank (C2T2), a group of hospitals and medical facilities that treat patients with the MRIdian system and which are dedicated to gathering evidence with respect to MR-guided radiation therapy.
 

To view the Privacy Policy, please click here.

To learn more about the multi-center, prospective, single-arm clinical trial for inoperable, locally advanced or borderline resectable pancreatic cancer, please provide your contact information via the form below. We will send you more information as it becomes available.

Please do not fill out this form if you are a patient or a patient's family member or friend.

Thank you.